(Q36980294)

17 August 2017

1 reference

title

Hypertension in pregnancy: an emerging risk factor for cardiovascular disease (English)

1 reference

17 August 2017

0 references

cardiovascular disease

1 reference

1 reference

2

Suzanne R Hayman

1 reference

17 August 2017

1

Vesna D Garovic

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Nature Clinical Practice Nephrology

17 August 2017

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

613-622

1 reference

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Fetal origins of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Leptin: the tale of an obesity gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Cardiovascular sequelae of toxaemia of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Is normal pregnancy atherogenic?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Long term effects of childbearing on health

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Reproductive history and coronary heart disease risk in women

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

The remote prognosis of eclamptic women. Sixth periodic report

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Long-term effect of preeclampsia on blood-pressure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Relation between infants' birth weight and mothers' mortality: prospective observational study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Recognition of the long-term sequelae of eclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

A prospective controlled five-year follow-up study of primiparas with gestational hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Blood pressure of young mothers and their children after hypertension in adolescent pregnancy: six- to nine-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Long term follow-up of women with hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Remote prognosis of preeclampsia in women 25 years old and younger

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

The risk of maternal ischaemic heart disease after gestational hypertensive disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Death rates from ischemic heart disease in women with a history of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Cardiovascular death in women who had hypertension in pregnancy: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Nitric oxide dysfunction in the pathophysiology of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Is cellular fibronectin a biological marker for pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Biochemical corroboration of endothelial involvement in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Insulin resistance syndrome in preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Lipoprotein atherogenicity: an overview of current mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Platelet activation in obese women: role of inflammation and oxidant stress

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Free leptin is increased in normal pregnancy and further increased in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Mechanisms of oxidation, antioxidants, and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

The neutrophil and preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Short- and long-term changes in plasma inflammatory markers associated with preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Clotting inhibitors and fibronectin as potential markers in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Thrombophilia and pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Homocysteine and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Dyslipoproteinaemia in postmenopausal women with a history of eclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Association of maternal endothelial dysfunction with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Microalbuminuria after pregnancy complicated by pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Pre-eclampsia and the maternal cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

A study of angiotensin II pressor response throughout primigravid pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

In search of fewer independent risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Cardiovascular and thromboembolic events following hypertensive pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Long-term mortality after preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0623

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0623

1 reference

17 August 2017

1 reference